Nicotine exposure and Parkinson disease

Area of Science:

• Neuroscience
• Epidemiology

Background:

• An observed inverse relationship exists between smoking and Parkinson disease (PD).
• Nicotine, a psychoactive compound in tobacco, has been hypothesized to offer neuroprotection against PD.
• Previous studies suggest smokers have a reduced risk of developing PD.

Purpose of the Study:

• To investigate the nicotine protection hypothesis in Parkinson disease.
• To analyze detailed smoking histories and nicotine exposure in PD cases and controls.
• To determine if nicotine exposure correlates with age of onset or disease severity.

Main Methods:

• A case-control study design was employed.
• Cases with Parkinson disease were compared to sex-, race-, and age-matched controls.
• Detailed smoking histories were collected to estimate nicotine exposure before symptom onset.

Main Results:

• Estimated mean nicotine exposure was 186.1 g for smoking PD cases and 208.3 g for smoking controls (p = 0.34).
• No significant relationship was found between nicotine exposure and PD severity among cases.
• Age at onset of symptoms was not delayed in smoking PD cases compared to nonsmoking cases.

Conclusions:

• The study found no further support for the nicotine protection hypothesis in Parkinson disease.
• The inverse relationship between smoking and PD is likely due to factors other than nicotine's neuroprotective effects.
• Alternative explanations include selective mortality or pre-disease behavioral/constitutional changes.